A federal appeals court has ruled that, just as terminally ill patients have a right to die and refuse treatment, they also have a right to take all measures available to them to sustain their lives. The court’s ruling allows dying patients access to experimental drugs that have passed the first phase of FDA review, which determines whether a product is safe, even prior to full FDA approval.
The FDA objected to the court’s ruling, saying that it already has programs in place that make potentially lifesaving drugs available before final approval.
Click here to see the WashingtonPost.com article:
http://www.washingtonpost.com/wp-dyn/content/article/2006/05/02/AR2006050201470.html
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.